Renal stimulation tests document the dynamic response of the glomerular filtration rate (GFR) after a single or a combination of stimuli, such as an intravenous infusion of dopamine or amino acids or an oral protein meal. The increment of the GFR above the unstimulated state has formerly been called the renal functional reserve (RFR). Although the concept of a renal reserve capacity has not withstood scientific scrutiny, the literature documenting renal stimulation merits renewed interest. An absent or a blunted response of the GFR after a stimulus indicates lost or diseased nephrons. This information is valuable in preventing, diagnosing and prognosticating acute kidney injury and pregnancy-related renal events as well as chronic kidney disease. However, before renal function testing is universally practiced, some shortcomings must be addressed. First, a common nomenclature should be decided upon. The expression of RFR should be replaced by renal functional response. Second, a simple protocol must be developed and propagated. Third, we suggest designing prospective studies linking a defective stimulatory response to emergence of renal injury biomarkers, to histological or morphological renal abnormalities and to adverse renal outcomes in different renal syndromes.
INTRODUCTION
Glomerular filtration rate (GFR) is considered the best overall index of kidney function. It is dependent on age, gender, ethnicity, body composition and diet [1] as well as nephron endowment [2] . GFR is determined by the measured clearance of certain exogenous markers or endogenous waste products. In everyday practice, clinicians usually rely on estimated GFR (eGFR) calculated from a single serum marker measurement, mostly creatinine. However, such estimates have several limitations. Estimating equations are valid only in steady-state conditions. Moreover, analytical variation of serum creatinine measurements (2% for enzymatic assays), variation in tubular secretion and dependency on muscle mass [3] should be factored in.
Often ignored, GFR is not constant, as the kidneys do not continuously function at maximum filtration capacity [4] . It is estimated that in healthy subjects, kidneys usually operate at 75% of their maximal GFR. Renal function is influenced by diurnal cycles [5] and is stimulated by protein-containing meals. Thus, single-point assessments of renal function ignore varying rates of glomerular filtration, as kidneys are capable of adjusting their performance to haemodynamic and metabolic demands.
In 1930, Verney mentioned the reserve forces of the kidney [6] . In analogy with myocardial and pulmonary function, a redundant or dormant renal reserve was hypothesized, intended to cope with extraordinary haemodynamic and metabolic demands. Fifty years later, Bosch called this the renal functional reserve (RFR), defined as the difference between the baseline GFR and the stimulated GFR, measured 2 h after a protein meal [7] .
Over the years, enthusiasm for the RFR concept abated [8] [9] [10] [11] [12] , until Ronco and colleagues [4, [13] [14] [15] and Molitoris [16] recently revived interest in this concept. They postulate that diminished RFR contributes to the susceptibility for recurrent acute kidney injury (AKI). These authors argue that evaluation of the degree of functional recovery post-AKI is not only clouded by the loss of muscle mass but also by stimulated single-nephron GFR to compensate for nephron loss. Testing the renal functional response in these recovered patients could possibly unveil this undetected loss of functional units and could identify patients at risk for progression to chronic kidney disease (CKD). This hypothesis was discussed and reviewed at the Fifth International Conference of the French Society of Intensive Care [17, 18] .
Additionally, a deficit in RFR has been incriminated in pregnancy-related kidney disease [19] . Further, study of the diagnostic and prognostic utility of RFR has been mentioned in the roadmap for global kidney health 2017, issued by the International Society of Nephrology [20] . Finally, the promotion of high-protein diets to lose weight stimulated renewed attention to the postprandial behaviour of the GFR.
Reviewing the literature on RFR is impeded by a myriad of definitions and stimulatory tests. This article aims to propose a synthesizing lexicon and tries to offer a variety of protocols for future directions of research.
LEXICON
The RFR (also referred to as renal reserve capacity) is defined as the difference between the stimulated GFR and the baseline GFR. This difference can be expressed in absolute terms (mL/ min) or in relative terms (percentage of increment relative to the baseline GFR). Although a straightforward and simple definition at first sight, terminologies and definitions are quite confusing. Table 1 proposes a revised nomenclature in the context of renal functional testing. The expression of RFR should be replaced by renal functional response.
The baseline or basal GFR is sometimes referred to as unstimulated GFR (as opposed to stimulated GFR) or unstressed GFR (to better differentiate it from the GFR in stressed circumstances) and finally resting GFR. While the resting GFR is the lowest normal GFR, it is not identical to the baseline GFR used in the context of AKI, which is usually defined as the best or highest GFR preceding an AKI episode [17, 21] .
To maximally guarantee an unstimulated (lowest) GFR, patients are often instructed to adhere to a low-protein or vegetarian diet in preparation for a renal stimulation test. If the person is not instructed to do so, the test results (actual GFR and maximal increase) should be interpreted in the light of the usual protein intake of the subject. This can be derived from the urea nitrogen level in timed urine collection. Coincidentally, patients with CKD often follow a low-protein diet. This increases the value of a stimulatory test.
The stimulated or stressed GFR is the measured GFR following a stimulus, including an oral protein load, an intravenous amino acid (AA) solution, a glucagon infusion or a dopamine drip [22] . Rodríguez-Iturbe et al. [23] defined a tubular stress test, describing the tubular secretion of intravenously injected creatinine. Regretfully, a creatinine solution marketed for intravenous use in human experiments is currently not available (personal inquiry). As creatinine is readily absorbed by the gastrointestinal tract, an oral creatinine load is safer and might result in a comparable tubular challenge [24] . Recently a furosemide stress test was applied to patients with progressive AKI, discriminating recovery from progression [25] . Thus renal stimuli are either of a metabolic or haemodynamic nature. A protein meal, when composed of cooked meat, challenges the kidney with both AA and creatinine. This stimulus can be considered a combination of both a metabolic and a tubular stimulus.
Descriptions of the numerous alternative tubular challenges (sodium, potassium, phosphorus, acid, water deprivation and water loading) is beyond the scope of this review.
After stimulation and in healthy subjects, the GFR can reach 180-200 mL/min. Some authors refer to GFR in this range as hyperfiltration. Cachat et al. [26] reviewed the literature in 2015 and Tonneijck et al. [27] recently described the mechanisms of diabetic hyperfiltration. These authors correctly differentiate between whole kidney function as opposed to single-nephron function. On a single-nephron level, hyperfiltration is assumed when the intraglomerular pressure is elevated, causing albuminuria and in the long-term leading to progressive glomerulosclerosis. Single-nephron hyperfiltration does not automatically translate into whole-kidney hyperfiltration, quite the opposite: glomerular hyperfiltration is often intended to preserve a waning whole-kidney GFR in the face of a diminishing nephron number [28] . More recently, high GFR values were also noted in septic intensive care unit (ICU) and post-operative patients. We advocate the use of augmented renal clearance for seemingly physiological adaptations and the use of stimulated GFR in the context of RFR.
PHYSIOLOGY OF METABOLIC RENAL STIMULATION
For a more extensive overview of the functional compensation after a protein meal, we refer the reader to excellent reviews by Gabbai [29] , Bankir et al. [30] , Helal et al. [31] , King and Levey [1] and Premen [32] . Any metabolic stimulus triggers the kidneys to increase the GFR primarily by reducing the overall renal vascular resistance (RVR) and inducing a postprandial renal hyperaemia. This increase of the renal blood flow results from systemic mediators as well as paracrine factors, both acting on the whole kidney level as on the single-nephron GFR. Initially, recruitment of quiescent glomeruli in ill-perfused regions was hypothesized, hence the term 'renal functional reserve' [7, 33] . Later it was concluded that the increased GFR results from a higher filtration effort of all single nephrons, almost exclusively attributed to a higher effective renal plasma flow (ERPF).
The feed-forward stimulus after a protein load or an increase in AA plasma levels originates from the pancreas and the liver [30] . A higher ratio of glucagon to insulin stimulates the liver in favour of nitrogen handling and helps the kidneys in the disposal of urea. The hepatic production of cyclic adenosine monophosphate (cAMP) operates as a second messenger. On the single-nephron level, glucagon and cAMP cooperate to reduce the tubular solute concentration at the macula densa. In this way, the tubuloglomerular feedback is downregulated. As a result, vasodilation of the pre-glomerular arteries and arterioles induces an increase in the single-nephron GFR. Intrinsic renal autoregulation with nitric oxide, vasodilating prostaglandins and kinins is responsible for this action. Inhibition of renal autocrine prostaglandin synthesis with indomethacin counteracts the vasodilatory effects of AAs. The hypothalamic-hypophyseal axis contributes to this process. Vasopressin or the antidiuretic hormone (ADH) is also active in stimulating the GFR after a protein meal. Together with glucagon, this hormone helps in the processing of protein metabolites. The role of growth hormone seems of less importance, as a protein meal equally elicits a functional renal response in growth hormonedeficient patients [34, 35] .
In the long term, the afferent arteriole is evidently the weak spot in these consecutive events, as this site harbours the first signs of hypertensive hyalinosis, impeding maximal relaxation [36] . Arterial stiffness proved to be an independent predictor of adaptive glomerular hyperfiltration after kidney donation [37] . If the ERPF is not able to keep pace with the increased demands, the efferent vasoconstriction gradually prevails, leading to a higher intraglomerular pressure and filtration fraction (FF). This additive mechanism, triggered by the renin-angiotensin system with thromboxane A2 and endothelin-1 as cofactors, leads to a cascade of negative events. In the long run, a higher FF might lead to glomerular as well as tubular injury and a loss of nephrons. Treatment with an angiotensin-converting enzyme (ACE) inhibitor has been shown to restore the GFR response after a protein stimulation [38] . Table 2 provides an overview of the chronology and methodology of a renal stimulation test. The numerous stimuli and modes of GFR measurements are described in the following paragraph.
METHODOLOGY OF RENAL STIMULATION TESTS

Measurement of unstimulated GFR
Several factors may influence the unstimulated GFR. First, hydration status [39] is a very important confounding variable. Spinelli et al. [40] advise the use of bio-impedance measurements to identify dehydrated subjects. For this reason, most protocols adopt a strict oral hydration policy, starting with 10-20 mL/kg plain water and replacing each voided urine sample with an equal amount of oral fluids. Hypovolaemia also blunts the renal response after stimulation [38] . Second, the body must remain in the fasting state for at least 8 h (overnight fasting). A low-protein or vegetarian diet for 10 days preceding the test is advised by some authors to ascertain a true unstimulated GFR. Doubt remains if this interval succeeds in normalizing glomerular hypertrophy caused by a chronically high-protein diet. If the investigator does not advocate this preparatory phase, habitual protein intake can be estimated from urea nitrogen in a 24-h urine collection [41] and the extent of GFR stimulation must be interpreted with this knowledge. Finally, besides a thorough non-pharmacological preparation, some drugs must be paused, as they interfere with renal vascular adaptation. These include non-steroidal antiinflammatory drugs (NSAIDs) [42] , ACE inhibitors and angiotensin receptor blockers.
Selecting the proper stimulus
Measuring the stimulated GFR requires maximal recruitment of the so-called reserve GFR. Several approaches have been advocated, which-broadly speaking-can be divided into haemodynamic and metabolic stimuli.
In humans, a significant increase of the GFR has been described with glucagon infusions at a rate of 10-20 ng/kg/min. More frequently, dopamine is used. This vasoactive drug augments the ERPF and hence the GFR without affecting cardiac output or systemic vascular resistance. The FF usually drops slightly when dopamine is infused at a dose of 2.0 mg/kg/min. This is the result of afferent and preferentially efferent arteriolar dilation [43] . At the single-nephron level, the increased filtration seems totally attributable to higher plasma flow in combination with lower transcapillary pressure. Sometimes dopamine is the only renal stimulus used, for instance, in a dopamine-induced glomerular response test [44] . Dopamine provocation may be combined with a metabolic stimulus. When combined with an AA infusion, the effects are additive [45] . During the AA infusion, ERPF and GFR increase proportionally with a predominant afferent arteriolar dilation resulting in a constant FF. The composition of the AA solution depends on local availability, but gluconeogenic AA should be present [46] , whereas branched-chain AAs do not alter GFR or FF [47] . The infusion rates reported in the literature are disparate. The AA infusion can begin the night before the test day, but the GFR response is already present after a 1-or 2-h infusion time. A dose-response curve for AA stimulus was constructed by Giordano et al. [48] . Within the physiological range, incremental AA concentrations cause a stepwise increase in the GFR, whereas this effect levels off in the pharmacological range.
The administration of a single AA to elicit a change in GFR is also reported. Arginine [49, 50] and glycine have been used, each acting via different pathways. Arginine causes systemic and renal vasodilation, while glycine operates via the Nmethyl-D-aspartate glutamate receptor (NMDA-R) [29] . This receptor is localized in the proximal tubule and functions as a calcium channel, causing local vasodilation.
A more natural approach is to stimulate the GFR by a protein meal. This short-term oral protein loading should consist of at least 1 g/kg of protein [51] . Rodríguez-Iturbe et al. [52] studied three quantities of protein meals: 1.3, 1.1 and 0.55 g/kg. The filtration fraction rose significantly with the moderate and large protein load but not with the lower protein load.
Animal proteins are preferred, so most centres prepare a cooked beef hamburger. Red meat, however, contains 3.5-5 mg/g creatine. By cooking, a non-metabolic conversion of creatine to creatinine occurs [53] . This metabolite is easily absorbed and the rising serum levels result in increased tubular secretion until the tubular transport maximum is reached [54] . Accordingly, the more pronounced response (after a protein challenge) of creatinine clearance (CrC) compared with inulin clearance is due to a higher input and increased tubular secretion of creatinine. Alternatives for animal protein are dairy products and eggwhite proteins. These are more practical in paediatric subjects [55] . Vegetable proteins, for instance soy products or bean curd, are less effective in stimulating the GFR [56] . Many reasons for this difference have been postulated, including a different AA mixture, less sulphur-containing AA, less oxidative stress or acid load, lower maximal AA serum levels, faster internalization in the cells due to a different insulin/glucagon surge, less sodium and more potassium content. An elaborate description of the renal benefits attributed to a vegetarian diet is beyond the scope of this article. The reader is referred to excellent reviews by Kalantar-Zadeh et al. [57] and Snelson and Fouque [58] .
The renal response after a haemodynamic stimulus is immediate while the maximal effect of a metabolic stimulus is noted after 1-3 h. Recent evidence shows that in obese nondiabetic subjects, the maximal rise in GFR after a protein stimulus is postponed [59] .
Over the years, no major side effects of renal stimulation tests have been observed. In the different studies, blood pressure and heart rate were carefully monitored, especially when dopamine was used as a stimulating agent. After the stimulus has waned renal function returns to its unstimulated state. Intravenous perfusion of a hyperosmolar AA solution has been found to cause local pain and phlebitis. No increase in urinary neutrophil gelatinase-associated lipocalin or proteinuria has been documented in the protein stimulation experiments performed by Sharma et al. [51] . N-acetyl glucosaminidase (NAG) has been studied in immunoglobulin A nephropathy (IgAN) during RFR testing [60] , but the serial documentation of damage biomarkers, including albuminuria, remains largely unexplored.
Measuring GFR during renal stimulation tests
The Achilles heel of renal function testing is the method used for GFR determination [61] . Urinary inulin clearance remains the most extensively reported method in renal stimulation tests. This classic mode of GFR measurement is often combined with para-aminohippuric acid (PAH) clearance to document the ERPF. Delanaye et al. [62] delineates the difficulties of this technique, including costs, variances in lab techniques and availability. Zitta et al. [44] succeeded in studying GFR behaviour after AA infusion via the plasma kinetics of sinistrin and hippurate supplied to a two-compartment computer model. The advantage of this technique is the elimination of urine collections.
The easiest alternative for the use of inulin is to monitor urinary CrC by timed urine collections (30 or 60 min), considering known caveats when using this biomarker. At least three clearance calculations are advised. The CrC overestimates true GFR because of additive tubular secretion, leading to a mean bias of 14 mL/min or 25% [63] . The overestimation depends on baseline kidney function. However, when subjects are asked to adhere to a low-protein diet of 0.5 g/kg/day, calculated CrCs are similar to inulin clearance [64, 65] . When urinary CrC is used not only as a GFR estimator but also to track accessory tubular secretion, the intake of drugs that inhibit the tubular secretion of creatinine must be avoided (e.g. trimethoprimsulfamethoxazole, cimetidine and possibly fenofibrate). On the other hand, when the investigator wants to capture solely the dynamics of glomerular filtration, tubular secretion of creatinine can be blocked by cimetidine. This results in the cimetidineaided CrC (CACrC). In the publication by Hilbrands et al. [66] , cimetidine was started 1-4 days prior to the GFR stimulus according to a dosing protocol determined by the actual renal function.
Irrespective of the methodology, investigators must ascertain complete voiding or resort to placing a bladder catheter (mostly done in children, which increases the invasiveness of the test).
We do not advocate GFR estimating formulas (Chronic Kidney Disease Epidemiology Collaboration formula or Cockcroft-Gault formula] to document the renal functional response. Some authors propose cystatin C measurements [67, 68] . The kinetics of this functional biomarker have been tested after protein meals, with conflicting results [69, 70] .
Alternative possibilities for measuring the GFR before and after a stimulus are urinary or plasma clearances of isotopes, e.g. 51 Cr-labeled ethylenediaminetetra-acetic acid (Cr-EDTA), 125 I-labeled iothalamate [45] and 99m Tc-labeled diethylenetriaminepenta-acetic acid (Tc-DTPA) (see Tables 4  and 5 Recently an elegant technique of urinary clearance of iohexol was tested in an ICU population with varying GFRs [71] . The protocol describes a bolus injection followed by a continuous infusion of a low dose of iohexol combined with regular plasma and urine sampling. This technique seems applicable in renal function testing. In the meantime, progress is being made in the development and validation of fluorescent markers for GFR determination. These intravenously injected compounds behave as an ideal renal filtration marker. Their plasma disappearance curves match glomerular filtration and can be read transdermally thanks to their fluorescent properties. In this way, an almost real-time GFR evaluation is possible [72, 73] . Table 3 describes in more detail the advantages and disadvantages of the numerous options.
Alternatives to GFR measurements
Magnetic resonance imaging (MRI) holds great promise, as it allows for simultaneous measurements of both the GFR and renal plasma flow (RPF) [74] , as well as providing estimates of single-nephron GFR. Additionally, MRI could be used to quantify renal fibrosis, as recent evidence suggests [75] .
Doppler ultrasound can detect the decrease in RVR occurring in healthy kidneys after a protein challenge [76, 77] . This has led investigators to study the renal resistive index variation (RRIV) before and after an AA infusion. A similar decrease in RVR can be documented when pressure is applied to the retroperitoneal vasculature. This autoregulatory reflex is intended to preserve the GFR. Maximal renal vasodilation was recorded when a saline bag representing 10% of the body weight was placed on the abdomen. The maximal RRIV observed in these experiments correlated with the RFR, thus offering a non-invasive real-time evaluation of the changing RVR [78] .
CLINICAL SUPPORT OF RENAL STIMULATION TESTING
Over the last three decades, numerous publications have reported on the renal stimulation test in various healthy and diseased populations (summarized in Tables 4 and 5 ). An exhaustive literature search of RFR testing proves very challenging because of the heterogeneous nomenclature, necessitating several surveys and meticulous scrutiny of the references. Surprisingly, only a minor fraction of studies investigated >50 subjects. Molina et al. [79] decided on a sample size of 384 children, considering a standard deviation of the GFR of 620 mL/min to find a pre-post difference of at least 2 mL/min. Despite this fundamental statistical consideration, most papers omit biological variance and inter-person variability in their discussions.
The first studies were performed in healthy individuals (Table 4) . Several different stimuli were used. It was shown that inulin clearances could rise to 130-150 mL/min while CrCs reached 160-180 mL/min [7] . These studies also demonstrated that the protein content of the habitual diet influences unstimulated GFR and determines the absolute extent of the GFR increase after a protein load [80] [81] [82] . Hypovolaemia is an appreciated cause of a blunted response [38] . Healthy elderly individuals show a lower GFR and less effect after stimulation, most probably because they rely on fewer nephrons [83] [84] [85] . Recently Denic et al. [86] demonstrated that the single-nephron GFR (in unstimulated circumstances) remained remarkably stable in a large cohort of living kidney donors until the age of 70 years. The age-dependent decline of the GFR in elderly donors was attributed to a lower nephron count and a lower metabolic need without the presence of kidney disease.
Tabe 3. Advantages and disadvantages of the different options mentioned in Table 1 Option Pros Cons Evaluation Normal controls show an increase in GFR and ERPF. CGN with preserved GFR showed no increase in ERPF, while patients with lower GFR showed no effect on GFR while ERPF increases (continued) Overweight people show an increased unstimulated GFR and less exploitable filtration capacity [87] .
Kidney donors as well as patients with a congenital single kidney were extensively studied ( Table 5 ). The expected response after a fixed protein meal or an AA infusion is generally preserved in single kidneys, even several years after nephrectomy. Dopamine accomplishes less stimulatory effect, as ERPF is already maximally increased [45] . Long-term follow-up reveals that the gradual increase in the GFR in the post-transplant period is achieved by glomerular hypertrophy instead of an increased ERPF [88] . Regazzoni et al. [89] described an unchanged GFR several years after a nephrectomy in childhood. However, an oral protein load proved gradually less effective in evoking an adequate response. Transplanted kidneys show less response to a protein stimulus when treated with cyclosporine compared with patients treated with a calcineurin-free regimen, mostly azathioprine [90] . The extent of the GFR increment after a stimulus correlated with kidney size (i.e. length or volume). Kidneys from younger donors exhibited a better renal response after a stimulus and this was dependent upon the unstimulated GFR of the donor [91] . The native kidneys of patients after a heart transplantation tended to show less response than the single transplanted kidney [92] . This was attributed to pre-existent cardiovascular damage, absence of renal denervation or a slightly higher cyclosporine trough level.
Hypertensive patients challenged with a protein meal, demonstrate a weaker or absent renal response. The presence of albuminuria indicates subclinical damage with abolished filtration reserve. A significant negative correlation was shown between the renal response and the renal resistive indices, evaluated by ultrasound [77] . In the offspring of hypertensive parents, the RFR proved lower and was associated with albuminuria [93] . Fifteen patients planned for a coronary angiography were matched with as many healthy peers. Their ERPF was lower and correlated with the extent of coronary lesions [94] . No response on AA infusion could be documented in patients with coronary artery disease.
IgAN cases were studied after AA and dopamine infusions. A diminished renal response was present in patients with more prominent histological lesions (with >50% of the glomeruli showing proliferation and >15% of the glomeruli with crescents or segmental lesions) [95] . Another study correlated a lower GFR increase to injury biomarkers such as proteinuria and NAG excretion [60] .
Livi et al. [96] studied patients suffering from systemic sclerosis and found that they displayed a lower stimulated GFR. Followed for 5 years, scleroderma patients without increasing GFR at the start lost kidney function at a faster rate of >2 mL/min/year. This study is one of the rare prospective reports. Children tested after a previous episode of haemolytic uremic syndrome showed variable response after a protein meal. Low responders (<36% increase) developed proteinuria later in life [97] .
When renal function is decreasing, the amount of exploitable filtration capacity decreases but stays measurable even in patients with Stage 4 CKD [98] . This contrasts with the former theory of RFR, claiming that the reserve capacity is fully utilized before the GFR drops below 50 mL/min [80] .
In a small study, 10 compensated patients with mild heart failure showed no vasodilatory response after AA infusion. The response was restored after initiation of an ACE inhibitors [99] .
A higher GFR is observed in diabetics with hyperglycaemia. In these circumstances, the renal blood flow and the filtration fraction are increased, resulting in a higher intraglomerular pressure. This leads to transient or permanent albuminuria [27] .
Diabetic patients with overt proteinuria fail to respond with a GFR increase when challenged with a protein meal [100] [101] [102] [103] .
In pregnancy, the induced augmented renal clearance (we deliberately avoid using the phrase 'hyperfiltration') is observed because of an increased ERPF thanks to relaxin, a vasodilating hormone produced by a healthy placenta. Pregnancy offers the most extensive increment of GFR [104] . The filtration fraction of kidneys in pregnancy is normal or decreased [105] . Only normotensive gravida display a functional response [106] . Failure to fully dilate the afferent arteriole and augment ERPF may lead to pre-eclampsia or pregnancy-related hypertension [104] . Hence the interest in examining the RFR in women with kidney disorders consulting with a pregnancy wish.
CRITICAL APPRAISAL OF RENAL STIMULATION TESTING
The idea of a dormant and exhaustible RFR was flawed as soon as it became obvious that single and transplanted kidneys still show a functional improvement after a protein load [10] . This observation led to waning interest in renal function testing and resulted in incomplete scientific explorations: not all renal syndromes have been thoroughly tested. Correlations with histological findings are hardly reported. Moreover, there are no reference data in sickness or in health. Furthermore, longitudinal data linking a decreased stimulatory effect to unfavourable outcomes are scarce. Today, the use of RFR measurements has no place in routine clinical care.
A second criticism is the missing of a renal distress signal, making renal and cardiac stress testing hard to compare. An absent functional response and/or the demonstration of a higher filtration fraction could be viewed as a surrogate for renal maladaptation, potentially leading to progressive nephron loss. This parameter can only be documented when renal clearances of a filtration and a perfusion marker (PAH or 131 I-hippuran or 99 M Tc-mercaptoacetyltriglycine) are followed simultaneously.
Without the emergence of injury biomarkers, a normal renal response after a protein load implies normal protein tolerance. In contrast to cardiac stress testing providing the clinician with an early diagnosis allowing for targeted treatment, renal function testing offers the clinician a suggestion of subclinical pathology, but without therapeutic consequences.
A concern is the terminology used. The literature is with confounding nomenclature and consensus definitions are missing.
Renewed interest in renal function testing has been stimulated by nephrologists involved in AKI care. A metabolic challenge could be valuable in assessment of the renal recovery. However, the causative link of diminished renal protein tolerance to a higher susceptibility for recurrent AKI remains debatable.
Finally, renal function testing is relatively labour intensive and requires the allocation of resources. Because the test remains in the experimental context, it is not reimbursed. Spinelli et al. [40] performed a cost calculation of a simple RFR test using cooked beef as a stimulus and four urine CrC measurements added to 8 h of a nurse's workload. The total cost was e91 for a single RFR estimation. Costs were predominantly driven by the nursing workload, so actual costs may vary substantially between different regions of the world.
FUTURE DIRECTIONS OF RESEARCH
The first step to be taken is deciding on a common vocabulary. We propose to use the terminology of unstimulated GFR (when all confounding variables are controlled for), random GFR and stimulated GFR. We also advocate rephrasing the terminology of RFR, although firmly embedded in the literature, to renal functional response.
Second, two standard protocols of renal function testing can be proposed, varying in complexity from an elaborate research methodology (encompassing exogenous markers) to a simple scheme with calculated renal CrCs by the means of timed urine collections. However, recent evidence points to the important contribution of tubular secretion in the clearance of proteinbound retention products [107] . The tubular contribution to overall renal clearance can be evaluated by simultaneously measuring the clearance of creatinine and an exogenous filtration marker, either after a protein meal or a creatinine load. Alternative stimuli should be explored, for instance serelaxin [108] .
Third, prospective studies in different disease entities are necessary to link an abnormal renal response to major adverse renal endpoints and provide us with reference values. In Table 6 we present four clinical situations in which the absent response after stimulation might yield meaningful diagnostic and prognostic information: subjects before kidney mass reducing surgery or known to have a diminished number of nephrons, patients in which renal disease is assumed and individuals with an augmented renal clearance. When the eGFR is low, a significant stimulatory response indicates a sufficient nephron quantity. In the case of a diminished or absent increase, CKD can be ascertained. Subjects at high cardiovascular risk may present with a preserved eGFR. If a renal stimulation test fails to induce an increment of glomerular filtration, these patients can be diagnosed as having subclinical kidney disease. A lower as well as a higher GFR have been associated with increased cardiovascular risk [109] . No renal response might indicate single-nephron hyperfiltration in both circumstances.
The complexity of the stimulation protocol should match the importance of the anticipated result. Hence the study of kidney donor candidates might receive the greatest attention: maximal stimulus (dopamine in combination with an AA infusion) combined with measured GFR by an exogenous marker. Women at high risk for pre-eclampsia or pregnancy-induced hypertension might be solicited to participate in a simple protein challenge study with urinary CrC. Also, patients applying for bariatric surgery might be tested: an absent functional response could provide the multidisciplinary team with a sense of urgency. Will these patients regain their glomerular reactivity along with the expected reduction of proteinuria [110] ? Tubular function testing can be interesting in patients with chronic obstructive pulmonary disease or obstructive sleep apnea, with both showing a high prevalence of kidney disease. Can RFR testing before and after starting nocturnal continuous positive airway pressure sort out the questions in this syndrome regarding cause, effect or merely association? Post-AKI patients can be evaluated before they leave the ICU by means of an AA infusion and timed urinary CrCs. In this way, their renal recovery status is better documented and can be correlated with future events. Doig et al. [111] published a randomized controlled trial in an ICU population of an AA infusion as a preventive strategy for AKI: the primary endpoint was negative but eGFR and urine production increased. Repetitive testing of the glomerular and tubular reserve by a protein load in patients after cystectomy and urinary diversion, might elucidate progressive tubulointerstitial damage even before serum creatinine rises. Finally, to broaden the scientific foundation of renal function testing, studying the behaviour of renal damage biomarkers during renal stimulation might offer more insight into glomerular and tubular adaptation. Moreover, functional data should be coupled to histological information. Morphological details acquired by MRI or ultrasound can provide additional elements. Obviously these lines of research will greatly amplify the cost of renal function testing and can only be initiated in the context of a study. Eventually comparison of these divergent diagnostic procedures can guide us in choosing the most cost-effective procedure to gain deeper insight into renal health. Several relevant clinical trials (www.clinicaltrials.gov) are under way or are awaiting publication. One trial (NCT03190070) includes 30 participants and is testing a liquid protein load in normal and CKD subjects. A second trial (NCT03190070) included 110 patients scheduled for cardiac surgery and performed RFR testing 1 day before and 3 months after the procedure as well as urinary TIMP2-IGFPB7 analysis. Another trial (NCT03190070) plans to monitor 100 patients with a partial laparoscopic nephrectomy and intends to compare the renal protective effect of total versus segmental renal artery clamping by studying the RFR.
CONCLUSIONS
This article offers the most extensive review of renal function testing to date. The authors propose a synthesizing lexicon and advocate a limited number of protocols applicable in future research.
A renal stimulation or stress test aims to document the capacity of an individual to increase his or her kidney function in response to a metabolic need. The stimuli that are proposed are derived from both physiological and experimental evidence. Offering a short-term oral protein load, for instance, mimics a normal meal and probes the integrity of the gutliver-kidney axis. This protein challenge tests glomerular as well as tubular function. Confirmation of an increasing GFR after a stimulus is meaningful. It implies an associated decrease of RVR. To accomplish this, the kidneys' vascular reactivity as well as a critical number of pre-glomerular arterioles must be preserved.
This dynamic test of a vital organ, shows analogies with stress tests in other clinical domains. Preservation of a renal haemodynamic and/or metabolic response might imply overall vascular health to overcome planned or unintentional injurious events.
With the available evidence, measurement of the renal functional response remains restricted to research purposes. Without prospective studies delivering reference data and acknowledging that renal iconographic and biomarker research is moving at great speed, a requiem rather than a revival for renal function testing is equally possible.
